Whether you're looking to lose weight, lower your blood sugar or address other health concerns, these are the best GLP-1 treatments online.
While Americans see the benefits of GLP-1s, skepticism about relying on an injection to lose weight still runs deep, a new survey finds.
Search trends and survey data show where interest in weight loss drugs like Ozempic and Wegovy is surging in America.
Noom’s microdose GLP-1 program says 70% of users report no side effects and lose up to 17 pounds in 60 days with behavior change support.
At the ATN Summit, fitness leaders weighed how gyms can stay relevant in the GLP-1 era by focusing on accountability and long-term health.
A new survey from AlynMD reveals shifting attitudes toward weight loss medications like Ozempic and which generation is most on board.
With a pharma giant in its corner, WeightWatchers is mounting a comeback, relying on FDA-approved GLP-1 medications.
Novo Nordisk ends its Wegovy deal with Hims & Hers, citing safety concerns as the telehealth firm pushes back.
WeightWatchers partners with U.K.-based CheqUp to expand GLP-1 support, following news of its Chapter 11 and focus on long-term growth.
ISSA launches a GLP-1 support course to help fitness pros guide clients through weight loss, behavior change and long-term health success.
Sign Up to Our Newsletter
